Angle Share Discussion Threads

[arthur_lame_stocks] 14/10/2022 10:39

I bought another 10k today. If this doesn't prove to be worth substantially more than £150m in time then I'll give my money back to the professionals to invest.

[1liam] 14/10/2022 09:39

Keep away if you have any sense until this hits 20p

[purchaseathetop] 14/10/2022 09:34

I do feel the a US listing will be damaging.

[purchaseathetop] 14/10/2022 09:32

In my opinion we’re close to free fall point where I think you should buy buy buy. Truly like gold nuggets.

[1liam] 14/10/2022 09:19

Another one of Purchaseatthetop blinding buys..... NotNo fun on the other board discussing a decomposing corpse.

[mrkeysersoze] 14/10/2022 07:26

Worth a read as a comparision of AIM v US Listing



Mr K.

[asdb9] 13/10/2022 21:02

I wouldn't read too much into it, we know what it's worth when everything comes together. Just the Solaris deal alone. We know the study will be a success, they are not doing the study for no reason. They have 750k patients per anum

[1liam] 13/10/2022 20:19

40s is fast approaching.

[amaretto1] 13/10/2022 18:00

It also does not match what's being put out with Trinity or proactive..And crucially Andrew Newland..Are they just talking about lab revenues ? The liquid biopsy space is set for literally billions in 2023 alone.

[amaretto1] 13/10/2022 17:51

I'm very dubious how this paper was released..... SK might like to enlighten me, as he was the one that posted it on this thread first ....

[amaretto1] 13/10/2022 17:48

Just come off the telephone to one of our institutional share holders. Amongst other things AGL .. we talked about the Jeffries paper....In her words, she basically did not know how those figures were complied ... and disputed them on several grounds ....One being contract roll outs etc ....Take with a pinch of salt, we are expecting far excess of those figures.Odviously dependant on roll out !!

[hsdeo] 13/10/2022 17:00

the Telegram group is much better

[stevelauren23] 13/10/2022 16:55

Oh good, I'm pleased I haven't been filtered 😂

[pldazzle] 13/10/2022 16:47

Stevel - no, not you!

[stevelauren23] 13/10/2022 16:38

Pldazzle, I'd been debating whether or not to post something similar all day. I'm agree with everything you've said. Hopefully I'm not one of the people you've filtered 😂😂

[asdb9] 13/10/2022 16:31

OK, What would you have done differently, for the third time

[asdb9] 13/10/2022 16:29

Agreed, his posting history is almost exclusively to bombard share forums slating the CEOs and directors. He never comments on the tech or the product, probably because that would mean he would have to research it. All he does is collect board members names and slate them. He will never provide evidential reason, and when questioned for his reasoning he goes and hides or moves on to the next company. Look what has happened here today 7 negate posts, all garbage about the board, I ask what he would have done differently and he disappears.

[supernumerary] 13/10/2022 16:21

Finally you post the truth.

[fevertreeman] 13/10/2022 16:18

Incorrect - great management team, strong NEds, clear path to profitability, great product....

[halland75] 13/10/2022 16:13

Convict...

"I have simply stopped looking at this share price".

Hilarious!
I would too buddy, good luck on the 11 hour shift 🤣🤣🤣

[supernumerary] 13/10/2022 16:08

More likely he's gone to play elsewhere under another id, having decided that a bottom's in here.

Of his claimed portfolio there was only one company I also own - Surface Transforms, where, despite his profligate advice to management here, he's never said a single word, including during the recent ugly little fund raising that hit the share price badly. Another share he doesn't actually own.

[purchaseatthetop] 13/10/2022 15:52

I have simply stopped looking at this share price. Only just over the 40p I started buying at when we had nothing to show for anything. Madness.

[asdb9] 13/10/2022 14:24

If you want to shut down the barrow boy(fevertree) just ask what he would have done. Then he goes quiet. Surprising for an expert advisor who used to sell his services to to Nasdaq biotech companies